Concepedia

Christina S. Imburgia

CS

Statistics

Publications

6

Citations

779

H-Index

6

Active since

1997

Affiliations

New Frontier(Current)

Molecular Discovery (United Kingdom)

Christina S. Imburgia is an author at New Frontier specializing in life sciences, chemokine signaling, and inflammatory signaling.

Publications per year

1997–2000

6

Publications

6

An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.

Jeffrey R. Jackson, Aidan G. Gilmartin, Christina S. Imburgia et al. · PubMed · 2000 · 233 citations

, , +17

The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase

Amy Roshak, Elizabeth A. Capper, Christina S. Imburgia et al. · Cellular Signalling · 2000 · 214 citations

, , +15

Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils

John R. White, Christina S. Imburgia, Edward Dul et al. · Journal of Leukocyte Biology · 1997 · 162 citations

, , +17

Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration

John R. White, Judithann M. Lee, Kimberly Dede et al. · Journal of Biological Chemistry · 2000 · 122 citations · Full text

, , +17

Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activity.

Colin H. Macphee, Edward R. Appelbaum, Kyung Johanson et al. · PubMed · 1998 · 24 citations

, , +17

1–5 of 6